Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.

doi:10.1007/s13277-013-1386-7

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Apr 2014

Gao Lei, Feng Zhenjun, Li Qiang, Li Lianqing, Chen Lei, Xiao Taiwu

Abstract excerpt

Fibroblast growth factor receptor 4 (FGFR4) is expressed in various cell types and plays important roles in regulating immune responses. Evidence has shown that FGFR4 rs351855 (Gly388Arg) polymorphism may act as a risk factor for many diseases. In the current study, we investigated the association between FGFR4 polymorphisms and the susceptibility to non-Hodgkin's lymphoma (NHL) in the Chinese population. Two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Lymphoma, Non-Hodgkin

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Risk

Source

Open in PubMed

Identifiers

PMID: 24248544
DOI: 10.1007/s13277-013-1386-7

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.PMID 24248544Read ↗

Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.Semantic proximity Read ↗

C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.Semantic proximity Read ↗

Risk of genome-wide association study-identified genetic variants for non-Hodgkin lymphoma in a Chinese population.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Semantic proximity Read ↗

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.Semantic proximity Read ↗

CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.Semantic proximity Read ↗

Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.Semantic proximity Read ↗

A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis.Semantic proximity Read ↗

A functional TNFRSF5 gene variant is associated with risk of lymphoma.Semantic proximity Read ↗

Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study.Semantic proximity Read ↗

[Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].Semantic proximity Read ↗

FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.